Oncogene-addicted NSCLC highlights from WCLC24 and ESMO24 – Lung Connect
Herbert Loong shared a post by LUNG CONNECT on LinkedIn, adding:
“Thanks LUNG CONNECT for providing me w/ opportunity to discuss key abstracts in Oncogene Addicted lung cancers presented at International Association for the Study of Lung Cancer WCLC24 & ESMO – European Society for Medical Oncology ESMO24!
Whirlwind tour of 7 abstracts in 7mins! Be sure to download associated slides for in depth info as they become available!”
Quoting LUNG CONNECT:
“Oncogene-addicted NSCLC highlights from WCLC24 and ESMO24
Dr. Herbert H. F. Loong holds several prominent positions in oncology. He is the Chair-Elect of the International Affairs Committee, a Scientific Track Member (2022-2024), and the Track Leader for Sarcoma (2023) at the American Society of Clinical Oncology (ASCO). Additionally, he has been promoted to Steering Committee Member at the Lung Cancer Policy Network. Dr. Loong is also the Chairperson of the Asia Pacific Coalition against Lung Cancer, a Board Member of the Connective Tissue Oncology Society, and a Committee Member of the International Association for the Study of Lung Cancer. He is an Associate Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong (CUHK).
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dr Herbert Loong, MBBS FRCP FASCO (Hong Kong) shares his views on new oncogene-addicted non-small cell lung cancer (NSCLC) data from two major conferences: the World Conference on Lung Cancer (WCLC) and the European Society for Medical Oncology Congress, ESMO 2024. Watch his update below:
Dr Herbert Loong, MBBS FRCP FASCO reviews the data and shares his key clinical takeaways from the following studies:
TRUST-II: (Liu G, et al. Abstract MA06.03, WCLC 2024.)
LOXO-RAS-20001: (Fujiwara Y, et al. Abstract OA14.04, WCLC 2024.)
DESTINY-Lung03: (Planchard D, et al. Abstract OA16.05, WCLC 2024.)
SOHO-01: (Le X, et al. Abstract PL04.03, WCLC 2024.)
Beamion LUNG-1: (Ruiter G, et al. Abstract PL04.04, WCLC 2024.)
ALKOVE-1: (Drilon A, et al. Abstract 1253O, ESMO 2024.)
MARIPOSA: (Besse B, et al. Abstract LBA55, ESMO 2024.)
Back here soon with a accompanying summary slide set……..
This programme is supported by an Independent Education grant from Bayer.”